[go: up one dir, main page]

YU45655B - Postupak za dobijanje 1-heteroaril-4-/(2,5 pirolidindion-1-il) alkil/piperazinskih derivata - Google Patents

Postupak za dobijanje 1-heteroaril-4-/(2,5 pirolidindion-1-il) alkil/piperazinskih derivata

Info

Publication number
YU45655B
YU45655B YU156384A YU156384A YU45655B YU 45655 B YU45655 B YU 45655B YU 156384 A YU156384 A YU 156384A YU 156384 A YU156384 A YU 156384A YU 45655 B YU45655 B YU 45655B
Authority
YU
Yugoslavia
Prior art keywords
defined above
alkyl
hydrogen
formula
substituted phenyl
Prior art date
Application number
YU156384A
Other languages
English (en)
Other versions
YU156384A (en
Inventor
J.S. New
J.P. Yevich
Original Assignee
Bristol Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Company filed Critical Bristol Myers Squibb Company
Priority to YU210386A priority Critical patent/YU45809B/sh
Publication of YU156384A publication Critical patent/YU156384A/xx
Publication of YU45655B publication Critical patent/YU45655B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/54—Preparation of carboxylic acid anhydrides
    • C07C51/56—Preparation of carboxylic acid anhydrides from organic acids, their salts, their esters or their halides, e.g. by carboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

POSTUPAK ZA DOBIJANJE 1-HETEROARIL-4-/(2,5 PIROLIDINDION-1-IL) ALKIL/PIPERAZINSKIH DERIVATA, formule: ili njihovih farmaceutski prihvatljivih adicionih soli sa kiselinama, gde R1 predstavlja C1-4 alkil, trifluorimetil ili Z-supstituisani fenil, pri cemu je Z vodonik ili halogen: ili R1 sa R2 gradi C4-5 alkilenski most inkorporira kondenzovan Z-supstituisani fenil, pri cemu je Z kao sto je definisano gore; ili R1, zajedno sa R3, obrazuje kondenzovani cikloheksenil prsten ili X1-X4 tetra-supstituisani fenil, pri cemu su X1-X4 nezavisno odabrani od vodonika, halogena ili nitro; R2 je C1-4 alkil ili Z-supstituisani fenil, gde je Z kao sto je definisano gore, ili R2, zajedno sa R1 gradi alkilenski most kao sto je definisano ranije; ili je R2 odsutno, a R1 i R3 grade kondenzovani prstenasti sistem kao sto je definisano gore; R3 je vodonik ili, zajedno sa R1, obrazuje kondenzovani prstenasti sistem kao sto je definisano gore; B predstavlja R4, R5-disupstituisani heterociklicni prstenasti sistem odabran iz grupe koja se sastoji od benzoizotiazola, piridina i pirimidina, pri cemu su R4 i R5 nezavisno odabrani od C1-4 alkil, C1-4 alkoksi, C1-4 alkiltio, cijano, halogena i vodonika; i n je 2-4; nazna cen time, sto jedinjenje formule: u kojoj su R1, R2 i R3 kao sto je definisano gore i predstavlja , ili , gde je n ceo broj od 2 do 4 i Q je pogodna grupa koja se zamenjuje, kao sto je hlorid, bromid, jodid, sulfat, fosfat, tozilat ili mezilat, reaguje sa jedinjenjem formule: gde je B kao sto je definisano gore; kada ima znacenje , tada je Y H2N-(CH2)n; kada predstavlja , tada je Y Q-(CH2)n ili i kada predstavlja , tada je Y vodonik; pod pogodnim reakcionim uslovima, tako da se dobije zeljeni proizvod formule (I) koji, prema potrebi, reaguje sa farmaceutski prihvatljivom kiselinom, tako da se dobije farmaceutski prihvatljiv. Prijava sadrzi jos 6 zavisnih zahteva.
YU156384A 1983-09-12 1984-09-10 Postupak za dobijanje 1-heteroaril-4-/(2,5 pirolidindion-1-il) alkil/piperazinskih derivata YU45655B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU210386A YU45809B (sh) 1983-09-12 1986-12-09 Postupak za dobijanje 1-heteroaril-4-/(2,5-pirolidindion-1-il)-alkil/-pipe raz kih derivata

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/531,519 US4524206A (en) 1983-09-12 1983-09-12 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Publications (2)

Publication Number Publication Date
YU156384A YU156384A (en) 1987-02-28
YU45655B true YU45655B (sh) 1992-07-20

Family

ID=24117966

Family Applications (2)

Application Number Title Priority Date Filing Date
YU156384A YU45655B (sh) 1983-09-12 1984-09-10 Postupak za dobijanje 1-heteroaril-4-/(2,5 pirolidindion-1-il) alkil/piperazinskih derivata
YU210386A YU45809B (sh) 1983-09-12 1986-12-09 Postupak za dobijanje 1-heteroaril-4-/(2,5-pirolidindion-1-il)-alkil/-pipe raz kih derivata

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU210386A YU45809B (sh) 1983-09-12 1986-12-09 Postupak za dobijanje 1-heteroaril-4-/(2,5-pirolidindion-1-il)-alkil/-pipe raz kih derivata

Country Status (33)

Country Link
US (1) US4524206A (sh)
JP (1) JPH0647586B2 (sh)
KR (1) KR890000566B1 (sh)
AR (1) AR241910A1 (sh)
AU (1) AU581858B2 (sh)
BE (1) BE900555A (sh)
CA (1) CA1285564C (sh)
CH (1) CH660484A5 (sh)
CS (1) CS258119B2 (sh)
CY (1) CY1538A (sh)
DD (1) DD224593A5 (sh)
DE (1) DE3433327C2 (sh)
DK (1) DK171990B1 (sh)
ES (1) ES8605797A1 (sh)
FI (1) FI83515C (sh)
FR (1) FR2555585B1 (sh)
GB (1) GB2146333B (sh)
GR (1) GR80320B (sh)
HK (1) HK84590A (sh)
HU (1) HU192439B (sh)
IE (1) IE58020B1 (sh)
IL (1) IL72854A (sh)
IT (1) IT1196250B (sh)
LU (1) LU85537A1 (sh)
NL (1) NL8402769A (sh)
NO (1) NO162384B (sh)
NZ (1) NZ209480A (sh)
OA (1) OA07809A (sh)
PT (1) PT79187B (sh)
SE (1) SE463368B (sh)
SU (1) SU1384199A3 (sh)
YU (2) YU45655B (sh)
ZA (1) ZA847065B (sh)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JPS61238784A (ja) * 1985-04-17 1986-10-24 Sumitomo Seiyaku Kk コハク酸イミド誘導体及びその酸付加塩
US4656173A (en) * 1985-04-24 1987-04-07 Bristol-Myers Company Antipsychotic benzisothiazole S-oxide compound
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
NZ216720A (en) * 1985-07-08 1990-09-26 Bristol Myers Co Diazinylpiperidine derivatives and pharmaceutical compositions
US4826843A (en) * 1985-07-08 1989-05-02 Bristol-Myers Cerebral function enhancing diazinylpiperidine derivatives
US4925841A (en) * 1985-07-22 1990-05-15 Temple University Of The Commonwealth System Of Higher Education Mannich bases of spirosuccinimides
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
US4757073A (en) * 1986-09-30 1988-07-12 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US4777254A (en) * 1986-12-02 1988-10-11 American Home Products Corp. Cyclic imides as H1 -antagonists
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
EP0635506A4 (en) * 1993-02-04 1995-04-12 Meiji Seika Co CONNECTION WITH ANTIPSYCHOTIC EFFECT.
US5338738A (en) * 1993-04-19 1994-08-16 Bristol-Myers Squibb Company Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
US6084097A (en) * 1997-10-20 2000-07-04 Council Of Scientific & Industrial Research Methods for preparing 1-[4-arylpiperazin-1-yl]-3-[2-oxopyrrolidin/piperidin-1-yl] propanes
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers
US6906191B2 (en) 1999-12-27 2005-06-14 Idemitsu Kosan Co., Ltd. Succinimide compounds and use thereof
JP2004514711A (ja) 2000-11-30 2004-05-20 ランバクシー　ラボラトリーズ　リミテッド 尿選択的アルファ１アドレナリン受容体遮断薬として有用な１，４−２基置換ピペラジン誘導体
US6660736B2 (en) * 2002-03-27 2003-12-09 Hoffmann-La Roche Inc. Phthalimido derivatives and a process for their preparation
JP2005527578A (ja) * 2002-04-08 2005-09-15 ランバクシー ラボラトリーズ リミテッド 有用な尿選択的α１Ａアドレナリン受容体遮断薬としてのα，ω−ジカルボキシイミド誘導体
DE602004017206D1 (de) * 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
EP1758583A2 (en) * 2004-05-31 2007-03-07 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as adrenergic receptor antagonists
US20060247249A1 (en) * 2005-11-16 2006-11-02 Mohammad Salman Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
AU2007221214A1 (en) 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2040706A2 (en) 2006-06-29 2009-04-01 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
HUE031039T2 (en) * 2007-03-29 2017-06-28 Joint-Stock Company Obninsk Chemical Pharmaceutical Company An antihistamine and an anti-allergenic agent and a method for its preparation
EP2625165B1 (en) 2010-10-05 2018-07-04 Syngenta Participations AG Insecticidal pyrrolidin-yl-aryl-carboxamides
UY34104A (es) 2011-05-31 2013-01-03 Syngenta Participations Ag ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
EP3896058A3 (en) 2011-10-03 2022-01-12 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
CN109438316A (zh) 2011-10-03 2019-03-08 先正达参股股份有限公司 杀虫的3-芳基-3-三氟甲基-取代的吡咯烷的对映选择性方法
WO2018172480A1 (en) 2017-03-23 2018-09-27 Syngenta Participations Ag Insecticidal compounds
WO2018172477A1 (en) 2017-03-23 2018-09-27 Syngenta Participations Ag Insecticidal compounds
WO2019243263A1 (en) 2018-06-19 2019-12-26 Syngenta Participations Ag Insecticidal compounds
US20220048876A1 (en) 2018-09-26 2022-02-17 Syngenta Participations Ag Insecticidal compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3558777A (en) * 1968-06-21 1971-01-26 Mead Johnson & Co Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
DK171990B1 (da) 1997-09-08
BE900555A (fr) 1985-03-11
DK433884A (da) 1985-03-13
GB2146333B (en) 1987-04-01
IL72854A0 (en) 1984-12-31
PT79187A (en) 1984-10-01
KR890000566B1 (ko) 1989-03-21
CS258119B2 (en) 1988-07-15
CS672184A2 (en) 1987-12-17
IT8422621A0 (it) 1984-09-11
FR2555585A1 (fr) 1985-05-31
IL72854A (en) 1988-03-31
PT79187B (en) 1986-11-24
SE8404552D0 (sv) 1984-09-11
SE463368B (sv) 1990-11-12
ZA847065B (en) 1985-04-24
AR241910A1 (es) 1993-01-29
JPS6084282A (ja) 1985-05-13
IT1196250B (it) 1988-11-16
NZ209480A (en) 1988-01-08
CY1538A (en) 1990-11-16
FI83515B (fi) 1991-04-15
YU156384A (en) 1987-02-28
IE58020B1 (en) 1993-06-30
AU3287084A (en) 1985-05-30
NO843579L (no) 1985-03-13
GB2146333A (en) 1985-04-17
FI83515C (fi) 1991-07-25
LU85537A1 (fr) 1985-04-29
DD224593A5 (de) 1985-07-10
SE8404552L (sv) 1985-03-13
SU1384199A3 (ru) 1988-03-23
FI843522L (fi) 1985-03-13
YU210386A (en) 1987-12-31
CH660484A5 (de) 1987-04-30
ES535780A0 (es) 1986-04-01
DK433884D0 (da) 1984-09-12
ES8605797A1 (es) 1986-04-01
DE3433327C2 (de) 1998-07-16
YU45809B (sh) 1992-07-20
NO162384B (no) 1989-09-11
GR80320B (en) 1985-01-14
HU192439B (en) 1987-06-29
JPH0647586B2 (ja) 1994-06-22
GB8422860D0 (en) 1984-10-17
CA1285564C (en) 1991-07-02
OA07809A (fr) 1986-11-20
NL8402769A (nl) 1985-04-01
DE3433327A1 (de) 1985-03-28
IE842311L (en) 1985-03-12
US4524206A (en) 1985-06-18
FR2555585B1 (fr) 1989-01-06
HUT36116A (en) 1985-08-28
KR850002483A (ko) 1985-05-13
FI843522A0 (fi) 1984-09-07
AU581858B2 (en) 1989-03-09
HK84590A (en) 1990-10-25

Similar Documents

Publication Publication Date Title
YU45655B (sh) Postupak za dobijanje 1-heteroaril-4-/(2,5 pirolidindion-1-il) alkil/piperazinskih derivata
YU30197A (sh) Derivati 4-hidroksi-piperidina, lekovi koji ih sadrže i postupci za njihovu proizvodnju
CY1299A (en) New 2,6-dimethyl-4,2,3-disubstituted phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid-3,5-asymmetric diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparation containing same
YU46526B (sh) Postupak za przvodnju derivata piridonkarboksilne kiseline
DK57281A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf
PH20114A (en) Dihydropyridines,pharmaceutical compositions containing the same and method of use thereof
ES8301881A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina que tienen actividad antiobesidad yno hploglicemi- ca.
EP0261964A3 (en) Azabicyclic compounds and their use as 5-ht3 receptor antagonists
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
YU45757B (sh) Postupak za dobijanje cikličnih imidnih derivata 2-(4-butilpiperazin-1-il)-piridina
DK162982C (da) 1,4-dihydropyridinderivater og farmaceutiske praeparater indeholdende disse
ATE17484T1 (de) Benzodioxan-imidazolin-verbindungen, verfahren zu deren herstellung und deren anwendung.
JPS56150047A (en) Nonaprenylamine derivative
ES485180A1 (es) Procedimiento para la preparacion de nuevos imidazo (1,2-a) imidazoles
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
DK161077C (da) Analogifremgangsmaade til fremstilling af 1,7-dihydropyrrol oe3,4-eaa-oe1,4aadiazepin-2(3h)-on-derivater eller farmaceutisk acceptable syreadditionssalte deraf
YU13197A (sh) Novi 2,3-benzodiazepinski derivati, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
ES8203828A1 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
SE7711211L (sv) Merkaptoalkylpyridiner och derivat